Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Chair, CEO buy Treatt's profit warning dip

(Sharecast News) - Flavour and fragrance ingredients maker Treatt disclosed two director share purchases on Monday, as its shares tumbled following a profit warning. The company said chairman Tim Jones bought a total of 8,944 shares across two transactions, taking his total interest to 67,032 shares, or 0.1% of its total voting rights.

In the first transaction he bought 5,328 shares for 560p each, spending a total of £29,836.80, while in the second he paid 559p apiece for 3,616 shares, for a total of £19,888.00.

Chief executive officer Daemmon Reeve, meanwhile, paid 559p per share for his single purchase of 3,556 shares, valuing the transaction at £19,878.04.

Following the purchase, Treatt said Reeve was interested in 544,056 shares, or 0.89% of its total voting rights.

On Monday morning, Treatt said that while it was still expecting to report strong revenue growth for the full-year and retained an "excellent" order book, it had been affected by a number of factors that would impact its full-year profitability.

It warned shareholders that it now expected profit before tax and exceptional items to be between £15m and £15.3m.

At 1306 BST, shares in Treatt were down 31.39% at 550.94p.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Globaldata (DATA) Director name: Harkness,Peter Amount purchased: 20,000 @ 1,264.00p Value: £252,800.01

Treatt (TET) Director name: Jones ,Tim Amount purchased: 5,328 @ 560.00p Value: £29,836.80

Treatt (TET) Director name: Jones ,Tim Amount purchased: 3,616 @ 550.00p Value: £19,888.00

Treatt (TET) Director name: Reeve,Daemmon Amount purchased: 3,556 @ 559.00p Value: £19,878.04

Regional Reit Limited (RGL) Director name: McGrath ,Kevin Amount purchased: 26,750 @ 74.30p Value: £19,875.25

Staffline Group (STAF) Director name: Spain,Thomas Amount purchased: 20,000 @ 39.20p Value: £7,840.00

Genflow Biosciences (GENF) Director name: Leire,Eric Amount purchased: 106,000 @ 2.80p Value: £2,968.00

United Utilities Group (UU.) Director name: Mogford,Steven L Amount purchased: 16 @ 1,120.70p Value: £179.31

United Utilities Group (UU.) Director name: Beardmore,Louise Amount purchased: 16 @ 1,120.70p Value: £179.31

United Utilities Group (UU.) Director name: Aspin,Phil Amount purchased: 16 @ 1,120.70p Value: £179.31

Xp Factory (XPF) Director name: Bird,Graham Amount purchased: 1,066 @ 14.90p Value: £158.83

Xp Factory (XPF) Director name: Harpham,Richard Amount purchased: 1,066 @ 14.90p Value: £158.83

Calnex Solutions (CLX) Director name: Greenan,Ashleigh Joanne Amount purchased: 94 @ 159.65p Value: £150.07

Calnex Solutions (CLX) Director name: Cook,Thomas (Tommy) Amount purchased: 94 @ 159.65p Value: £150.07

Aj Bell (AJB) Director name: Stott,Roger Amount purchased: 46 @ 326.00p Value: £149.96

Top Director Sells

Pendragon (PDG) Director name: Berman,William Amount sold: 1,363,228 @ 24.10p Value: £328,537.94

Globaldata (DATA) Director name: Lilley,Graham Amount sold: 20,000 @ 1,265.00p Value: £252,999.99

Pendragon (PDG) Director name: Willis,Mark Simon Amount sold: 749,775 @ 24.10p Value: £180,695.77

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.